Dannhardt G, Kiefer W, Krämer G, Maehrlein S, Nowe U, Fiebich B
Johannes Gutenberg-University of Mainz, Institute of Pharmacy, Staudingerweg 5, D-55099, Mainz, Germany.
Eur J Med Chem. 2000 May;35(5):499-510. doi: 10.1016/s0223-5234(00)00150-1.
Aroyl- and thiophene-substituted pyrrole derivatives have been synthesized as a new class of COX-1/COX-2 inhibitors. The inhibition of COX-1 was evaluated in a biological system using bovine PMNLs as the enzyme source, whereas LPS-stimulated human monocytes served as the enzyme source for inducible COX-2. The determination of the concentration of arachidonic acid metabolites was performed by HPLC for COX-1 and RIA for COX-2. Variation of the substitution pattern led to a series of active compounds which showed inhibition for COX-1 and COX-2. Structural requirements for the development of COX-1/COX-2 inhibitors are discussed.